Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium-catalyzed carbonylation method for alpha beta unsaturated thioesters. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN107628964B enables mild carbonylation for high-purity API intermediates. Reduces cost in fine chemical manufacturing with scalable Pd-catalyzed routes.
Patent CN109879792B details a Rh(III)-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharma intermediates with reduced steps.
Novel palladium-catalyzed carbonylation route offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN111777637B details novel indole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions.
Patent CN114920707B reveals a novel iodine-promoted synthesis of 3-trifluoromethyl-1,2,4-triazoles using DMF as a dual solvent and carbon source, offering significant cost reduction in API manufacturing.
Patent CN115010707B reveals metal-free synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing. High purity and scalable process.
Patent CN114573631A details a novel three-component reaction for paclitaxel side chains. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel palladium-catalyzed tandem reaction enables efficient one-step synthesis. Reduces steps and cost for pharmaceutical intermediates manufacturing significantly.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazole compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113880781B reveals glucose-based route for triazoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel indole-based phosphine ligands enable efficient C-S bond formation with high yields, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN118619879A reveals a novel Rhodium-catalyzed C-H activation route for trifluoromethyl enaminones, offering high purity and scalable pharmaceutical intermediate manufacturing.
Patent CN117865874A details Pd-catalyzed olefin C-H amination for tetrahydroindole derivatives, offering high purity and scalable synthesis for pharmaceutical intermediates.
Patent CN106674178A reveals a metal-free DBU-catalyzed route for chromans, offering high yields and reduced environmental impact for reliable pharmaceutical intermediate suppliers.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this scalable method.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and reduced operational hazards.
Patent CN114933570B reveals a mild copper-catalyzed route for 1,2,4-triazole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112920053B reveals a scalable, high-purity route for chiral amines used in asthma and oncology APIs, offering significant cost and safety advantages.
Patent CN104478678B reveals a ligand-free palladium method for alkyne ketones. This breakthrough ensures high purity, cost reduction, and reliable supply chain stability.